*The WeGene Personal Genome Service test includes genetic health risk reports. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: The WeGene Personal Genome Service Genetic Health Risk Report for Late-Onset Alzheimer’s Disease is indicated for reporting of the ε4 variant in the APOE gene. The report describes if a person has variants associated with a higher risk of Late-Onset Alzheimer’s Disease. This report does not include variants in other genes linked to Late-Onset Alzheimer’s Disease and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact Alzheimer’s Disease risk. The Personal Genome Service test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit https://www.wegene.com/en/intro/